Abstract
Monocyte/macrophage cells play a central role in innate immunity against C. neoformans and C. gattii, species known to cause human disease. Cryptococcus is the only fungal genus known to possess such a large extracellular polysaccharide capsule, which impacts interactions of innate cells with the yeast. This interaction results in different fates, such as phagocytosis and intracellular proliferation and, as the interaction progresses, vomocytosis, cell-to-cell transfer, lysis of macrophages, or yeast killing. Differentiating internalized versus external Cryptococcus cells is thus essential to evaluate monocyte–macrophage phagocytosis. We describe here a protocol that allows quantification of Cryptococcus spp. phagocytosis using quantitative flow cytometry in human monocytes and a murine macrophage cell line (J774).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bliska JB, Casadevall A (2009) Intracellular pathogenic bacteria and fungi – a case of convergent evolution? Nat Rev Microbiol 7(2):165–171
Bitar D, Lortholary O, Le Strat Y et al (2014) Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis 20(7):1149–1155
Rajasingham R, Smith RM, Park BJ et al (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17(8):873–881
Feldmesser M, Kress Y, Novikoff P et al (2000) Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68(7):4225–4237
Kronstad JW, Attarian R, Cadieux B et al (2011) Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol 9(3):193–203
Charlier C, Nielsen K, Daou S et al (2009) Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77(1):120–127
García-Rodas R, Zaragoza O (2012) Catch me if you can: Phagocytosis and killing avoidance by Cryptococcus neoformans. FEMS Immunol Med Microbiol 64(2):147–161
Jesus MD, Nicola AM, Chow S-K et al (2010) Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. Virulence 1(6):500–508
Levitz SM, DiBenedetto DJ (1989) Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol 142(2):659–665
McQuiston T, Luberto C, Del Poeta M (2011) Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. Microbiol Read 157(Pt 5):1416–1427
Ben-Abdallah M, Sturny-Leclère A, Avé P et al (2012) Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-κB. PLoS Pathog 8(3):e1002555
Kozel TR, Wilson MA, Pfrommer GS et al (1989) Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect Immun 57(7):1922–1927
Kozel TR, Pfrommer GS (1986) Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect Immun 52(1):1–5
Keller RG, Pfrommer GS, Kozel TR (1994) Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall. Infect Immun 62(1):215–220
Zaragoza O, Taborda CP, Casadevall A (2003) The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Eur J Immunol 33(7):1957–1967
Casadevall A, Cleare W, Feldmesser M et al (1998) Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42(6):1437–1446
Dromer F, Salamero J, Contrepois A et al (1987) Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun 55(3):742–748
Carreto-Binaghi LE, Aliouat EM, Taylor ML (2016) Surfactant proteins, SP-A and SP-D, in respiratory fungal infections: their role in the inflammatory response. Respir Res 17(1):66
Casadevall A, Coelho C, Alanio A (2018) Mechanisms of Cryptococcus neoformans-mediated host damage. Front Immunol 9:855
Taborda CP, Casadevall A (2002) CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16(6):791–802
Coelho C, Souza ACO, Derengowski L d S et al (2015) Macrophage mitochondrial and stress response to ingestion of Cryptococcus neoformans. J Immunol 194(5):2345–2357
Ikeda-Dantsuji Y, Ohno H, Tanabe K et al (2015) Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages. J Infect Chemother 21(12):831–836
Alanio A, Desnos-Ollivier M, Dromer F (2011) Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans. mBio 2(4):e00158–e00111
Levitz SM, Farrell TP (1990) Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect Immun 58(5):1201–1209
Walenkamp AM, Scharringa J, Schramel FM et al (2000) Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader. J Microbiol Methods 40(1):39–45
Alvarez M, Burn T, Luo Y et al (2009) The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes. BMC Microbiol 9:51
Coelho C, Tesfa L, Zhang J et al (2012) Analysis of cell cycle and replication of mouse macrophages after in vivo and in vitro Cryptococcus neoformans infection using laser scanning cytometry. Infect Immun 80(4):1467–1478
Srikanta D, Yang M, Williams M et al (2011) A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection. PLoS One 6(7):e22773
Mukherjee S, Feldmesser M, Casadevall A (1996) J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J Infect Dis 173(5):1222–1231
Alanio A, Vernel-Pauillac F, Sturny-Leclère A et al (2015) Cryptococcus neoformans host adaptation: Toward biological evidence of dormancy. mBio 6(2):e02580–e02514
Acknowledgments
The authors thank Marion Benazra for her helpful support and Professor Arturo Casadevall for providing the 18B7 mAb.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Lafont, E., Sturny-Leclère, A., Coelho, C., Lanternier, F., Alanio, A. (2024). Assessing Phagocytosis of Cryptococcus neoformans Cells in Human Monocytes or the J774 Murine Macrophage Cell Line. In: McClelland, E.E. (eds) Cryptococcus neoformans. Methods in Molecular Biology, vol 2775. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3722-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3722-7_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3721-0
Online ISBN: 978-1-0716-3722-7
eBook Packages: Springer Protocols